Patents by Inventor Steven Pullen

Steven Pullen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystal structure of the ITK kinase domain
    Publication number: 20070032403
    Abstract: Disclosed are polypeptides encoding the ITK kinase domain and nucleic acids encoding such polypeptides, crystal structures of various polypeptide-ligand complexes comprising the ITK kinase domain bound to a ligand, methods of producing the aforementioned polypeptides and nucleic acids which encode them and methods of producing crystal structures of the aforementioned polypeptides comprising the ITK kinase domain bound to a ligand.
    Type: Application
    Filed: December 23, 2004
    Publication date: February 8, 2007
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Joerg Bentzien, Bennett Farmer, Steven Pullen, Joey Studts, Andre White
  • Tec kinase inhibitors
    Publication number: 20050209284
    Abstract: Disclosed are compounds of formula(I): wherein Ar1, Ar2, R1, R2, R3, R4 and Xa are defined herein. The compounds of the invention inhibit Itk kinase and are therefore useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: February 9, 2005
    Publication date: September 22, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Joerg Bentzien, Brian Cook, Xiang Li, Ho Lo, Chuk Man, Ingo Mugge, Peter Nemoto, Steven Pullen, Doris Riether, Gregory Roth, Fariba Soleymanzadeh, Hidenori Takahashi, Ji Wang, Andre White, Renee Zindell
  • Substituted benzimidazole compounds
    Publication number: 20050203158
    Abstract: Disclosed are substituted benzimidazole compounds of formula (I): wherein R1, R2, R3, R4 and Xa are defined herein. The compounds of the invention inhibit Itk kinase and are therefore useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.
    Type: Application
    Filed: August 1, 2003
    Publication date: September 15, 2005
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Joerg Bentzien, Brian Cook, Charles Cywin, Roman Fleck, Ho Lo, Peter Nemoto, Steven Pullen, Gregory Roth, Roger Snow, Hidenori Takahashi, Ji Wang, Kevin Moriarty, Lei Qiao, Michael Winters